[Form 4] American Express Company Insider Trading Activity

Filing Impact

(High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

American Express Company (AXP) 鈥� Form 4 insider transaction

Chief Legal Officer Laureen Seeger disclosed sizeable share sales on 5鈥�6 Aug 2025. Key details:

5 Aug 2025: sold 39,383 shares at a weighted-average $297.24.
5 Aug 2025: sold 22,338 shares at a weighted-average $297.88.
6 Aug 2025: exercised 16,998 employee stock options (exercise price $177.06), acquiring the same number of shares.
6 Aug 2025: sold the 16,998 shares at a weighted-average $294.83.

Following these transactions, Seeger鈥檚 direct beneficial ownership fell from roughly 31,339 shares to 9,000.908, a reduction of about 71%. No derivative securities remain outstanding.

All reported prices represent volume-weighted averages; full price breakdowns are available upon SEC request. The filing does not indicate whether the trades were executed under a Rule 10b5-1 plan.

Insights

TL;DR: Large sell-down by AXP鈥檚 CLO trims holdings to 9k shares鈥攕ignals possible negative sentiment but may be routine.

The Chief Legal Officer disposed of approximately 78.7 k shares over two days, cutting her stake by ~71%. While insider selling is not automatically bearish, the magnitude and concentration over a short window stand out. No disclosure of a Rule 10b5-1 plan reduces the likelihood the trades were strictly pre-scheduled. Investors often view significant executive sales鈥攅specially near recent highs鈥攁s a mild negative signal regarding future upside. However, the exercise-and-sell pattern also suggests normal diversification following option vesting, limiting definitive conclusions.

TL;DR: Governance impact low; transaction is compliant and fully disclosed.

The Form 4 contains complete transactional detail, weighted-average pricing and a remaining holding disclosure, meeting Section 16 requirements. The option exercise matches the stated strike and expiration, indicating a routine incentive-plan event. Absence of a checked 10b5-1 box may draw extra investor scrutiny, but nothing in the filing suggests policy breaches or irregular timing. From a governance standpoint, the company鈥檚 disclosure controls appear effective; impact on governance risk profile is negligible.

08/07/2025 - 04:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Seeger Laureen

(Last)

(First)

(Middle)

200 VESEY STREET, AMERICAN EXPRESS TOWER

(Street)

NEW YORK

10285-5001

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
AMERICAN EXPRESS CO [ AXP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/05/2025		S		39,383	D	$297.24⁽¹⁾	31,338.908⁽²⁾	D
Common Stock	08/05/2025		S		22,338	D	$297.88⁽³⁾	9,000.908	D
Common Stock	08/06/2025		M		16,998	A	$177.06	25,998.908	D
Common Stock	08/06/2025		S		16,998	D	$294.83⁽⁴⁾	9,000.908	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$177.06	08/06/2025		M			16,998	01/28/2025	01/28/2032	Common Stock	16,998	$0	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $297.02 to $297.61. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

2. Includes shares acquired pursuant to dividend reinvestment.

3. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $297.62 to $298.48. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

4. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $294.53 to $295.24. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Remarks:

Exhibit 24: Power of Attorney

	/s/ James J. Killerlane III, attorney in-fact	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

AG真人官方